07:00 , Mar 25, 2013 |  BC Week In Review  |  Company News

Threshold, Siemens deal

Threshold acquired worldwide rights to develop and commercialize PET imaging tracer 18F-HX4 (flortanidazole) from Siemens' Siemens Healthcare unit. Threshold initially plans to develop 18F-HX4 to determine a patient's tumor hypoxia profile, but said the agent...